1. Home
  2. OVID vs NXPL Comparison

OVID vs NXPL Comparison

Compare OVID & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • NXPL
  • Stock Information
  • Founded
  • OVID 2014
  • NXPL 1997
  • Country
  • OVID United States
  • NXPL United States
  • Employees
  • OVID N/A
  • NXPL N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • NXPL Telecommunications Equipment
  • Sector
  • OVID Health Care
  • NXPL Telecommunications
  • Exchange
  • OVID Nasdaq
  • NXPL Nasdaq
  • Market Cap
  • OVID 20.6M
  • NXPL 17.9M
  • IPO Year
  • OVID 2017
  • NXPL N/A
  • Fundamental
  • Price
  • OVID $0.62
  • NXPL $0.76
  • Analyst Decision
  • OVID Strong Buy
  • NXPL
  • Analyst Count
  • OVID 4
  • NXPL 0
  • Target Price
  • OVID $3.13
  • NXPL N/A
  • AVG Volume (30 Days)
  • OVID 2.9M
  • NXPL 62.0K
  • Earning Date
  • OVID 08-12-2025
  • NXPL 08-13-2025
  • Dividend Yield
  • OVID N/A
  • NXPL N/A
  • EPS Growth
  • OVID N/A
  • NXPL N/A
  • EPS
  • OVID N/A
  • NXPL N/A
  • Revenue
  • OVID $548,000.00
  • NXPL $62,515,000.00
  • Revenue This Year
  • OVID N/A
  • NXPL N/A
  • Revenue Next Year
  • OVID $5.32
  • NXPL N/A
  • P/E Ratio
  • OVID N/A
  • NXPL N/A
  • Revenue Growth
  • OVID 15.61
  • NXPL 19.36
  • 52 Week Low
  • OVID $0.24
  • NXPL $0.43
  • 52 Week High
  • OVID $1.47
  • NXPL $2.30
  • Technical
  • Relative Strength Index (RSI)
  • OVID 68.33
  • NXPL 49.77
  • Support Level
  • OVID $0.60
  • NXPL $0.75
  • Resistance Level
  • OVID $0.73
  • NXPL $0.94
  • Average True Range (ATR)
  • OVID 0.07
  • NXPL 0.07
  • MACD
  • OVID 0.03
  • NXPL -0.00
  • Stochastic Oscillator
  • OVID 69.12
  • NXPL 18.18

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

Share on Social Networks: